13. Multiple sclerosis/Neuromyelitis optica Clinical trials / Disease details
Clinical trials : 3,342 / Drugs : 2,355 - (DrugBank : 406) / Drug target genes : 269 - Drug target pathways : 241
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT03001284 (ClinicalTrials.gov) | October 2012 | 8/12/2016 | Multiple Sclerosis Produces Cardiovascular Subclinical Dysfunction | Multiple Sclerosis | Other: NO intervention | Carol Davila University of Medicine and Pharmacy | NULL | Active, not recruiting | 18 Years | 65 Years | Both | 103 | N/A | NULL |